|Bid||7.90 x 1300|
|Ask||8.70 x 1000|
|Day's range||7.91 - 7.91|
|52-week range||5.08 - 10.44|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
SINGAPORE, July 03, 2018-- ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company based in Asia developing novel therapeutics for global markets, today announced the submission of a clinical ...
SINGAPORE, May 17, 2018-- ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe, ...